The trading price of Coherus Biosciences Inc (NASDAQ:CHRS) floating lower at last check on Monday, April 01, closing at $2.34, -2.17% lower than its previous close.
In examining the 52-week price action we see that the stock hit a 52-week high of $8.65 and a 52-week low of $1.43. Over the past month, the stock has gained 2.55% in value.
Coherus Biosciences Inc, whose market valuation is $260.38 million at the time of this writing, is expected to release its quarterly earnings report Mar 13, 2024. Investors’ optimism about the company’s current quarter earnings report is understandable. Analysts have predicted the quarterly earnings per share to grow by -$0.23 per share this quarter, however they have predicted annual earnings per share of -$0.72 for 2024 and $0.07 for 2025. It means analysts are expecting annual earnings per share growth of 63.60% this year and 109.70% next year.
Analysts have forecast the company to bring in revenue of $81.7 million for the current quarter, with the likely lows of $47.07 million and highs of $102 million. The average estimate suggests sales will likely up by 72.20% this quarter compared to what was recorded in the comparable quarter last year. From the analysts’ viewpoint, the consensus estimate for the company’s annual revenue in 2024 is $261.92 million. The company’s revenue is forecast to grow by 1.80% over what it did in 2024.
A company’s earnings reviews provide a brief indication of a stock’s direction in the short term, where in the case of Coherus Biosciences Inc No upward and no downward comments were posted in the last 7 days. On the technical side, indicators suggest CHRS has a 50% Sell on average for the short term. According to the data of the stock’s medium term indicators, the stock is currently averaging as a 50% Sell, while an average of long term indicators suggests that the stock is currently 100% Sell.
A quick review shows that CHRS’s price is currently 1.11% off the SMA20 and -1.95% off the SMA50. The RSI metric on the 14-day chart is currently showing 48.82, and weekly volatility stands at 6.30%. When measured over the past 30 days, the indicator reaches 8.62%. Coherus Biosciences Inc (NASDAQ:CHRS)’s beta value is currently sitting at 0.54, while the Average True Range indicator is currently displaying 0.19.
To see how Coherus Biosciences Inc stock has been performing today in comparison to its peers in the industry, here are the numbers: CHRS stock’s performance was -2.17% at last check in today’s session, and -63.92% in the past year.
An evaluation of the daily trading volume of Coherus Biosciences Inc (NASDAQ:CHRS) indicates that the 3-month average is 4.52 million. However, this figure has increased over the past 10 days to an average of 2.97 million.
Currently, records show that 112.22 million of the company’s shares remain outstanding. The insiders hold 4.67% of outstanding shares, whereas institutions hold 76.48%. The stats also highlight that short interest as of Mar 15, 2024, stood at 25.91 million shares, resulting in a short ratio of 9.28 at that time. From this, we can conclude that short interest is 22.99% of the company’s total outstanding shares. It is noteworthy that short shares in March were up slightly from the previous month’s figure, which was 25.32 million. However, since the stock’s price has seen -29.78% year-to-date, investors’ interest is likely to be reignited due to its potential to move even lower.
